http://www.zibb.com/all/theme/cq/Neurocrine+Biosciences+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 25 Nov 2009 21:00:15 GMTWed, 25 Nov 2009 21:00:15 GMT608831http://www.zibb.com/all/theme/cq/Neurocrine+Biosciences+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5694145/Neurocrine+Biosciences+NBIX+Corporate+Event+Announcement+NoticeNeurocrine Biosciences (NBIX) Expected next earnings release: Announcement date: 2/3/2010 - After Market Earnings Quarter: Q4 Announcement Status: Unconfirmed Expected next investor conference call information: Conference Call Date: 10/29/2009 Conference Call Time (ET): 8:30 AM Conference Call URL:http://www.zibb.com/article/5694145/Neurocrine+Biosciences+NBIX+Corporate+Event+Announcement+NoticeNeurocrine Biosciences IncorporatedWed, 25 Nov 2009 21:00:15 GMThttp://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-21st-annual-piper-jaffray-health-care-conference-72665922.htmlNeurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference. Live audio webcast Tuesday, December 1, 2009.http://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-the-21st-annual-piper-jaffray-health-care-conference-72665922.htmlNeurocrine Biosciences IncorporatedTue, 24 Nov 2009 17:00:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-16-2009/0005095303&EDATE=SAN DIEGO, Sept. 16 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the UBS Global Life Sciences Conference in New York.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-16-2009/0005095303&EDATE=Neurocrine Biosciences IncorporatedWed, 16 Sep 2009 16:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=156111&full=1SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX - News) announced today that the Company has entered into a Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited, a private investment group.http://www.biospace.com/news_story.aspx?StoryID=156111&full=1Neurocrine Biosciences IncorporatedWed, 16 Sep 2009 12:00:00 GMThttp://www.newratings.com/en/main/company_headline.m?id=1803081NEW YORK, September 4 (newratings.com) - Analysts at UBS reiterate their "neutral" rating on Neurocrine Biosciences Inc (ticker: NBIX). The target price has been raised from $5.50 to $6. [more]http://www.newratings.com/en/main/company_headline.m?id=1803081Neurocrine Biosciences IncorporatedFri, 05 Sep 2008 01:04:27 GMThttp://www.istockanalyst.com/article/viewarticle+articleid_2296062.htmlWe think Neurocrine Biosciences, Inc.'s (NBIX) stock is stuck in a tight trading range until investors get an update on either the future of its insomnia drug indiplon, or the phase II data on Gonadotropin-releasing hormone antagonist, elagolix. Both upda<ahttp://www.istockanalyst.com/article/viewarticle+articleid_2296062.htmlNeurocrine Biosciences IncorporatedWed, 18 Jun 2008 14:03:42 GMThttp://seekingalpha.com/article/65158-seattle-genetics-inc-q4-2007-earnings-call-transcript?source=feedComplete Story <img src="http://feeds.feedburner.com/~a/biotechstockblog?i=CcvL7a" border="0"http://seekingalpha.com/article/65158-seattle-genetics-inc-q4-2007-earnings-call-transcript?source=feedNeurocrine Biosciences IncorporatedTue, 19 Feb 2008 14:14:07 GMThttp://netleasenews.blogspot.com/2007/11/neurocrine-biosciences-enters-108.htmlThe foremost source for the latest news on sale leaseback transactions, lease financings, and the sale of single tenant and net leased real estate investments worldwide. Author: Patrick R. Mickeyhttp://netleasenews.blogspot.com/2007/11/neurocrine-biosciences-enters-108.htmlNeurocrine Biosciences IncorporatedFri, 28 Dec 2007 08:54:20 GMThttp://topics.nytimes.com/top/news/business/companies/neurocrine-biosciences-inc/index.htmlLunesta, a new sleeping pill approved for the market on Wednesday, will be the first whose label will not recommend it be taken for only 7 to 10 days.http://topics.nytimes.com/top/news/business/companies/neurocrine-biosciences-inc/index.htmlNeurocrine Biosciences Incorporatedhttp://www.zibb.com/article/5690418/Neurocrine+Biosciences+to+Present+at+the+st+Annual+Piper+Jaffray+Health+Care+ConferenceNeurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 21st Annual Piper Jaffray Health Care Conference in New York. The live presentation takes place Tuesday, December 1, 2009 at 4:30http://www.zibb.com/article/5690418/Neurocrine+Biosciences+to+Present+at+the+st+Annual+Piper+Jaffray+Health+Care+ConferenceNeurocrine Biosciences IncorporatedTue, 24 Nov 2009 12:00:00 GMThttp://www.zibb.com/article/5625323/Neurocrine+Biosciences+Reports+Third+Quarter+ResultsNeurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the quarter ended September 30, 2009. For the third quarter of 2009, the Company reported a net loss of $8.2 million, or $0.21 per share, compared with a net loss of $17.7 million, or $0.46 per share, for the samehttp://www.zibb.com/article/5625323/Neurocrine+Biosciences+Reports+Third+Quarter+ResultsNeurocrine Biosciences IncorporatedWed, 28 Oct 2009 16:05:00 GMThttp://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-conference-call-and-webcast-to-present-third-quarter-2009-financial-results-65809272.htmlNeurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results. CONFERENCE CALL AND WEBCAST THURSDAY, OCTOBER 29, 2009 COMPANY PRESENTATION AT THE OPPENHEIMER 20TH ANNUAL HEALTHCARE CONFERENCE LIVE AUDIO WEBCAST TUESDAY, NOVEMBER 3, 2009.http://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-conference-call-and-webcast-to-present-third-quarter-2009-financial-results-65809272.htmlNeurocrine Biosciences IncorporatedFri, 23 Oct 2009 18:05:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-15-2009/0005094685&EDATE=SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company has entered into a Committed Equity Financing Facility (CEFF) with Kingsbridge Capital Limited, a private investment group.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-15-2009/0005094685&EDATE=Neurocrine Biosciences IncorporatedTue, 15 Sep 2009 20:37:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=154879&full=1SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Thomas Weisel Partners Healthcare Conference in Boston. Ifhttp://www.biospace.com/news_story.aspx?StoryID=154879&full=1Neurocrine Biosciences IncorporatedThu, 03 Sep 2009 12:00:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-02-2009/0005087191&EDATE=SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Thomas Weisel Partners Healthcare Conference in Boston.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-02-2009/0005087191&EDATE=Neurocrine Biosciences IncorporatedWed, 02 Sep 2009 16:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=132357&full=1STUDY CONFIRMS EFFICACY IN VALIDATED ENDPOINTS; MIXED RESULTS IN EXPLORATORY ENDPOINTSCOMPANY TO HOST CONFERENCE CALL AND WEBCAST THURSDAY, MARCH 26TH AT 8:00AM ET / 5:00AM PTSAN DIEGO, March 25 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. today announcedhttp://www.biospace.com/news_story.aspx?StoryID=132357&full=1Neurocrine Biosciences IncorporatedThu, 26 Mar 2009 12:00:00 GMThttp://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/04-21-2008/0004796872&EDATE=CONFERENCE CALL AND WEBCAST SCHEDULED FOR WEDNESDAY, APRIL 30 SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its first quarter 2008 financial results after the Nasdaq market closes on Wednesday, April 30, 2008.http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/04-21-2008/0004796872&EDATE=Neurocrine Biosciences IncorporatedMon, 21 Apr 2008 18:00:00 GMThttp://www.zibb.com/article/5680297/Neurocrine+Biosciences+Down+Since+SmarTrend+s+Sell+RecommendationSmarTrend, our proprietary pattern recognition system, called a Downtrend for Neurocrine Biosciences (NASDAQ:NBIX) on October 02, 2009 at $2.88. Since then, Neurocrine Biosciences has returned 24.8% as of today's recent price of $2.17. Want to profit from these alerts? Go to www.mysmartrend.com nowhttp://www.zibb.com/article/5680297/Neurocrine+Biosciences+Down+Since+SmarTrend+s+Sell+RecommendationNeurocrine Biosciences IncorporatedThu, 19 Nov 2009 01:23:14 GMThttp://www.zibb.com/article/5654856/Neurocrine+Biosciences+Down+Since+SmarTrend+s+Sell+RecommendationSmarTrend, our proprietary pattern recognition system, called a Downtrend for Neurocrine Biosciences (NASDAQ:NBIX) on October 02, 2009 at $2.88. Since then, Neurocrine Biosciences has returned 22.6% as of today's recent price of $2.23. Want to profit from these alerts? Go to www.mysmartrend.com nowhttp://www.zibb.com/article/5654856/Neurocrine+Biosciences+Down+Since+SmarTrend+s+Sell+RecommendationNeurocrine Biosciences IncorporatedMon, 09 Nov 2009 13:30:50 GMThttp://www.zibb.com/article/5563299/Neurocrine+Biosciences+Amends+Corporate+Headquarters+LeaseNeurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company has entered into an amendment to its facility lease agreement. The amendment eliminates approximately 70,000 square feet of leased space. "We worked with our landlord in a collaborative manner to reduce our leasinghttp://www.zibb.com/article/5563299/Neurocrine+Biosciences+Amends+Corporate+Headquarters+LeaseNeurocrine Biosciences IncorporatedThu, 01 Oct 2009 16:15:00 GMThttp://www.zibb.com/article/5626582/Neurocrine+Biosciences+Down+Since+SmarTrend+s+Sell+RecommendationSmarTrend, our proprietary pattern recognition system, called a Downtrend for Neurocrine Biosciences (NASDAQ:NBIX) on October 02, 2009 at $2.88. Since then, Neurocrine Biosciences has returned 21% as of today's recent price of $2.28. Want to profit from these alerts? Go to www.mysmartrend.com nowhttp://www.zibb.com/article/5626582/Neurocrine+Biosciences+Down+Since+SmarTrend+s+Sell+RecommendationNeurocrine Biosciences IncorporatedWed, 28 Oct 2009 21:49:57 GMThttp://www.zibb.com/article/5618585/Neurocrine+Biosciences+NBIX+Corporate+Event+Announcement+NoticeNeurocrine Biosciences (NBIX) Expected next earnings release: Announcement date: 10/28/2009 - After Market Earnings Quarter: Q3 Announcement Status: Verified Expected next investor conference call information: Conference Call Date: 10/29/2009 Conference Call Time (ET): 8:30 AM Conference Call URL:http://www.zibb.com/article/5618585/Neurocrine+Biosciences+NBIX+Corporate+Event+Announcement+NoticeNeurocrine Biosciences IncorporatedMon, 26 Oct 2009 21:02:07 GMThttp://www.zibb.com/article/5608672/Neurocrine+Biosciences+Down+Since+SmarTrend+s+Sell+RecommendationSmarTrend, our proprietary pattern recognition system, called a Downtrend for Neurocrine Biosciences (NASDAQ:NBIX) on October 02, 2009 at $2.88. Since then, Neurocrine Biosciences has returned 5.2% as of today's recent price of $2.73. Want to profit from these alerts? Go to www.mysmartrend.com nowhttp://www.zibb.com/article/5608672/Neurocrine+Biosciences+Down+Since+SmarTrend+s+Sell+RecommendationNeurocrine Biosciences IncorporatedThu, 22 Oct 2009 01:32:07 GMThttp://www.zibb.com/article/5501298/Neurocrine+Biosciences+to+Present+at+the+Thomas+Weisel+Partners+Healthcare+ConferenceNeurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Thomas Weisel Partners Healthcare Conference in Boston. The live presentation takes place Wednesday, September 9, 2009 at 9:45http://www.zibb.com/article/5501298/Neurocrine+Biosciences+to+Present+at+the+Thomas+Weisel+Partners+Healthcare+ConferenceNeurocrine Biosciences IncorporatedWed, 02 Sep 2009 12:00:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/05-11-2009/0005023600&EDATE=If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/05-11-2009/0005023600&EDATE=Neurocrine Biosciences IncorporatedMon, 11 May 2009 16:00:00 GMT